FDA-Inspected Site

Lyne Laboratories, Inc.

14 FDA inspections are on record for Lyne Laboratories, Inc. in Brockton, United States.

483· Form 483 issued

Brockton, United States · Last updated August 15, 2026

Overview

  • 14 FDA inspections are on record.
  • 8 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-03-10.

At a glance

Inspections

14

Form 483s

8

EIRs

3

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
11 Feb 2026 – 10 Mar 2026Human Drugs483View 483 →
12 Oct 2022 – 21 Oct 2022Human Drugs483On file
7 Sep 2021 – 8 Sep 2021Foods & CosmeticsClean
10 Jan 2018 – 25 Jan 2018Human Drugs483View 483 →
28 Aug 2017 – 7 Sep 2017Human DrugsClean
8 Aug 2016 – 17 Aug 2016Human Drugs483View 483 →
27 Jan 2014 – 13 Feb 2014Human Drugs483View 483 →
25 Mar 2011Not recorded483View 483 →
5 Apr 2010Not recorded483View 483 →
26 Feb 2009Not recorded483View 483 →
5 Oct 2007Not recordedWL
7 Dec 2005Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

10 Mar 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Jonathan G Matrisciano, Ifechimere I Okafor

10 Mar 2026
21 CFR 211.122(a)

Sampling/testing of labeling/packaging materials

Cited by Jonathan G Matrisciano, Ifechimere I Okafor

10 Mar 2026
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Jonathan G Matrisciano, Ifechimere I Okafor

10 Mar 2026
21 CFR 211.58

Buildings not maintained in good state of repair

Cited by Jonathan G Matrisciano, Ifechimere I Okafor

10 Mar 2026
21 CFR 211.84(b)

Representative Samples

Cited by Jonathan G Matrisciano, Ifechimere I Okafor

Investigators

FDA investigators tied to this site in the record.

Megan A Haggerty2 insp.
Daniel L Zheng1 insp.
Rory Geyer1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations6x
21 CFR 211.100(a)Cited across public-safe Form 483 observations4x
21 CFR 211.110(a)Cited across public-safe Form 483 observations3x
21 CFR 211.22(d)Cited across public-safe Form 483 observations3x
21 CFR 211.160(a)Cited across public-safe Form 483 observations2x
21 CFR 211.25(a)Cited across public-safe Form 483 observations2x
21 CFR 211.46(b)Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)Cited across public-safe Form 483 observations2x
21 CFR 211.68(a)Cited across public-safe Form 483 observations2x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.110(d)Cited across public-safe Form 483 observations1x
21 CFR 211.111Cited across public-safe Form 483 observations1x
21 CFR 211.122(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.186(b)(9)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.194(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.46(c)Cited across public-safe Form 483 observations1x
21 CFR 211.52Cited across public-safe Form 483 observations1x
21 CFR 211.56(c)Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(c)(3)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Lyne Laboratories, Inc.'s 8 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat